Lorenzo Tonialini

Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP)

Anna Mele, Eleonora Del Prete, Clara De Risi et al. · Annals of Hematology · 2020 · 23 citations

Medicine, Hematology, Pharmacotherapy +15

90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years

Beatrice Casadei, Cinzia Pellegrini, Alessandro Pulsoni et al. · Cancer Medicine · 2016 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

Letizia Gandolfi, Cinzia Pellegrini, Beatrice Casadei et al. · The Oncologist · 2016 · 17 citations · Full text

Medicine, Hematology, Oncology +16

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

Alessandro Broccoli, Beatrice Casadei, Vittorio Stefoni et al. · BMC Cancer · 2017 · 16 citations · Full text

Medicine, Hematology, Oncology +13

High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

Enrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini et al. · BMC Cancer · 2015 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10